Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 197

The DOI matches its Crossref record.

Administration of Growth Hormone to Patients with Familial Dwarfism with High Plasma Immunoreactive Growth Hormone: Measurement of Sulfation Factor, Metabolic and Linear Growth Responses

LARON, Z., PERTZELAN, A., KARP, M., KOWADLO-SILBERGELD, A., DAUGHADAY, W. H. · 1971 · The Journal of Clinical Endocrinology & Metabolism

Abstract

Familial dwarfism with high plasma IR-HGH is a syndrome which is clinically indistinguishable from hereditary monotropic dwarfism due to lack of growth hormone (HGH) secretion. Furthermore, in both types of dwarfism there is a spontaneous hypoglycemia, hypoglycemia nonresponsiveness after the injection of insulin, and a reduced insulin response after arginine infusion. The metabolic and linear growth response to exogenous HGH was studied in 16 patients with this syndrome and compared to that in 19 patients with pituitary dwarfism due to HGH deficiency (isolated or concomitant with other hormones), as well as in 4 newborns and a patient with active acromegaly who had elevated concentrations of HGH in the plasma. A number of important differences in response were observed. After intravenous HGH administration, patients with familial dwarfism and high HGH had a smaller rise in plasma FFA than occurred in true pituitary dwarfs. Administration of HGH intramuscularly for 4 days induced no rise in plasma SF, less decrease in urinary nitrogen, and less prominent calciuria in familial dwarfs with high IR-HGH as compared to true pituitary dwarfs. Treatment of the familial dwarfs with high plasma IR-HGH with exogenous HGH for periods of 5–17 months failed to stimulate significant growth in most cases. As yet, we do not know just what is the basic defect in familial dwarfism with high plasma IR-HGH. The primary lack of a sulfation factor cannot readily explain the manifold metabolic changes found, with the exception of dwarfism. It is suggested that at least part of their resistance to exogenous HGH is due to saturation of peripheral tissue receptors of HGH by an abnormal GH. This hypothesis of competitive saturation is supported by the findings that newborns and a patient with acromegaly were resistant to the influence of exogenous HGH while the concentration of plasma HGH was high, but showed a normal response when HGH levels decreased.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jcem-33-2-332

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 197

Metadata

Authors
LARON, Z., PERTZELAN, A., KARP, M., KOWADLO-SILBERGELD, A., & DAUGHADAY, W. H.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
1971-08
Volume
33
Issue
2
Pages
332-342
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W1991088558
Cited by
197
References
0
FWCI
7.88
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Administration of Growth Hormone to Patients with Familial Dwarfism with High Plasma Immunoreactive Growth Hormone: Measurement of Sulfation Factor, Metabolic and Linear Growth Responses. https://app.cochat.ai/papers/10.1210/jcem-33-2-332
The paper
LARON, Z., PERTZELAN, A., KARP, M., KOWADLO-SILBERGELD, A., & DAUGHADAY, W. H. (1971). Administration of Growth Hormone to Patients with Familial Dwarfism with High Plasma Immunoreactive Growth Hormone: Measurement of Sulfation Factor, Metabolic and Linear Growth Responses. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jcem-33-2-332

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.